Frédérique Menzaghi
2014
In 2014, Frédérique Menzaghi earned a total compensation of $681.7K as Vice President - Research and Development at Cara Therapeutics, a 124% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,875 |
|---|---|
| Option Awards | $273,347 |
| Salary | $302,500 |
| Total | $681,722 |
Menzaghi received $302.5K in salary, accounting for 44% of the total pay in 2014.
Menzaghi also received $105.9K in non-equity incentive plan and $273.3K in option awards.
Rankings
In 2014, Frédérique Menzaghi's compensation ranked 9,169th out of 13,032 executives tracked by ExecPay. In other words, Menzaghi earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,169 out of 13,032 | 30th |
Division Manufacturing | 3,437 out of 4,966 | 31st |
Major group Chemicals And Allied Products | 1,161 out of 1,686 | 31st |
Industry group Drugs | 921 out of 1,365 | 33rd |
Industry Pharmaceutical Preparations | 707 out of 1,043 | 32nd |
Source: SEC filing on April 27, 2016.
Menzaghi's colleagues
We found four more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2014.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019